Vol. 19 No. 1 (2015)
REVIEWS

Endovascular treatment of acute coronary syndrome in patients with chronic obstructive pulmonary disease

PDF (Русский)
  • A. Namitokov,
  • V. Zafiraki,
  • Ye. Kosmacheva,
  • V. Porkhanov
A. Namitokov
Kuban State Medical University
Bio
V. Zafiraki
Kuban State Medical University
Bio
Ye. Kosmacheva
Kuban State Medical University
Bio
V. Porkhanov
Professor S. Ochapovsky 1st Regional Clinical Hospital
Bio
DOI: https://doi.org/10.21688/1681-3472-2015-1-95-100

Published 2015-10-10

Keywords

  • CHRONIC OBSTRUCTIVE PULMONARY DISEASE,
  • ACUTE CORONARY SYNDROME,
  • PERCUTANEOUS CORONARY INTERVENTION

How to Cite

Namitokov, A., Zafiraki, V., Kosmacheva, Y., & Porkhanov, V. (2015). Endovascular treatment of acute coronary syndrome in patients with chronic obstructive pulmonary disease. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 19(1), 95–100. https://doi.org/10.21688/1681-3472-2015-1-95-100

Copyright (c) 2015 Namitokov A.M., Zafiraki V.K., Kosmacheva Ye.D., Porkhanov V.A.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Analyzed in this overview are literature data on the results of percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS) in association with chronic obstructive pulmonary disease (COPD). Based on a number of large international studies, the role of COPD as an independent risk factor for both the ACS and PCI complications is demonstrated. The immediate and long-term outcomes of conservative and invasive management of such patients are described, with special emphasis placed on the design of the research done within the framework of national and multi-center programs. Debatable and challenging issues of the safety and prognosis of endovascular treatment in this group of patients are analyzed. A shortage of prospective studies with reliable verification of COPD diagnosis in accordance with relevant criteria is stated. The problem of comorbid COPD and ACS is proven to be of great importance. There is a strong need for further research in this area.
PDF (Русский)

References

  1. The top 10 causes of death. WHO site. http://www.who.int/media-centre/factsheets/fs310/ru/index2.html
  2. WHO, Media, centre. Fact sheet No 317. Secondary Fact sheet No 317 2013.
  3. European Heart Network and European Society of Cardiology. European Cardiovascular Disease Statistics http://www.escardio.org/about/documents/eu-cardiovascular-disease-statistics-2012.pdf
  4. О состоянии здоровья населения Краснодарского края в 2012 году: государственный доклад/Администрация Краснодарского края, Министерство здравоохранения Краснодарского края; под общей редакцией Е.Н. Редько. Краснодар: ГБУЗ МИАЦ. 196 с.
  5. Schnell K., Weiss C.O., Lee T. et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 19992008 // BMC Pulm Med. 2012. V. 12. P. 26.
  6. Сайт ВОЗ. Мировая статистика здравоохранения. http://www.who.int/gho/publications/world_health_statistics/2012/ru/
  7. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014.http://www.goldcopd.org/uploads/users/files/GOLD_Report2011_Russian.pdf
  8. Buist A.S., McBurnie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study // Lancet. 2007. V. 370. P. 741-750.
  9. Waatevik M., Skorge T.D., Omenaas E. et al. Increased prevalence of chronic obstructive pulmonary disease in a general population // Respir. Med. 2013. V. 107. P. 1037-1045.
  10. Vestbo J., Hurd S.S., Agusti A.G. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary // Am. J. Respir. Crit. Care Med. 2013. V. 187. P. 347-365.
  11. Hansell A.L., Walk J.A., Soriano J.B. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis // EurRespir J. 2003 Nov. V. 22 (5). P. 809-814.
  12. Rutten F.H., Moons K.G., Cramer M.J. et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study // BMJ. 2005 Dec 10. 331(7529). 1379. Epub. 2005. Dec 1.
  13. Engstrm C.P., Persson L.O., Larsson S. et al. Health-related quality of life in COPD: why both disease-specific and generic measures should be used // Eur. Respir. J. 2001 Jul. V. 18 (1). P. 69-76.
  14. Huiart L., Ernst P., Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005. Oct. V. 128 (4). P. 2640-2646.
  15. Behar S., Panosh A., Reicher-Reiss H. et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group // Am. J. Med. 1992. Dec. V. 93 (6). P. 637-641.
  16. Dziewierz A., Siudak Z., Rakowski T. et al. Relationship between chronic obstructive pulmonary disease and in-hospital management and outcomes in patients with acute myocardial infarction // Kardiol. Pol. 2010. V. 68. P. 294-301.
  17. Hadi H.A., Zubaid M., Al Mahmeed W. et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome // Clin. Cardiol. 2010. Apr; V. 33 (4). P. 228-235.
  18. Konecny T., Somers K., Orban M. et al. Interactions between COPD and outcomes after percutaneous coronary intervention // Chest. 2010 Sep; V. 138 (3). P. 621-627.
  19. Sung P.H., Chung S.Y., Sun C.K. et al. Impact of chronic obstructive pulmonary disease on patient with acute myocardial infarction undergoing primary percutaneous coronary intervention // Biomed. J. 2013 Nov-Dec; V. 36 (6). P. 274-281.
  20. Andell P., Koul S., Martinsson A. et al. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction // Open Heart 2014. V. 1. P. 1.
  21. Enriquez J.R, Parikh S.V, Selzer F, et al. Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry. Chest 2011 Sep;140(3):604-610.
  22. Zhang J.W, Zhou Y.J, Yang Q, et al. Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention. Angiology 2013. Aug; V. 64 (6). P. 430-434.